126 related articles for article (PubMed ID: 8207347)
1. Mucoadhesive ophthalmic vehicles: evaluation of polymeric low-viscosity formulations.
Saettone MF; Monti D; Torracca MT; Chetoni P
J Ocul Pharmacol; 1994; 10(1):83-92. PubMed ID: 8207347
[TBL] [Abstract][Full Text] [Related]
2. The effect of some macromolecular ionic complexes on the pharmacokinetics and -dynamics of ocular cyclopentolate in rabbits.
Huupponen R; Kaila T; Saettone MF; Monti D; Ilsalo E; Salminen L; Oksala O
J Ocul Pharmacol; 1992; 8(1):59-67. PubMed ID: 1402295
[TBL] [Abstract][Full Text] [Related]
3. Ophthalmic delivery systems based on drug-polymer-polymer ionic ternary interaction: in vitro and in vivo characterization.
Sandri G; Bonferoni MC; Chetoni P; Rossi S; Ferrari F; Ronchi C; Caramella C
Eur J Pharm Biopharm; 2006 Jan; 62(1):59-69. PubMed ID: 16162402
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of mucoadhesive polymers in ocular drug delivery. I. Viscous solutions.
Davies NM; Farr SJ; Hadgraft J; Kellaway IW
Pharm Res; 1991 Aug; 8(8):1039-43. PubMed ID: 1924157
[TBL] [Abstract][Full Text] [Related]
5. Gamma scintigraphic comparison of eyedrops containing pilocarpine in healthy volunteers.
Meseguer G; Buri P; Plazonnet B; Rozier A; Gurny R
J Ocul Pharmacol Ther; 1996; 12(4):481-8. PubMed ID: 8951684
[TBL] [Abstract][Full Text] [Related]
6. In vitro testing of thiolated poly(aspartic acid) from ophthalmic formulation aspects.
Budai-Szű Cs M; Horvát G; Gyarmati B; Szilágyi BÁ; Szilágyi A; Csihi T; Berkó S; Szabó-Révész P; Mori M; Sandri G; Bonferoni MC; Caramella C; Csányi E
Drug Dev Ind Pharm; 2016 Aug; 42(8):1241-6. PubMed ID: 26556306
[TBL] [Abstract][Full Text] [Related]
7. Influence of hydroxypropyl beta-cyclodextrin on the corneal permeation of pilocarpine.
Aktaş Y; Unlü N; Orhan M; Irkeç M; Hincal AA
Drug Dev Ind Pharm; 2003 Feb; 29(2):223-30. PubMed ID: 12648019
[TBL] [Abstract][Full Text] [Related]
8. Comparison of ion-activated in situ gelling systems for ocular drug delivery. Part 2: Precorneal retention and in vivo pharmacodynamic study.
Rupenthal ID; Green CR; Alany RG
Int J Pharm; 2011 Jun; 411(1-2):78-85. PubMed ID: 21453763
[TBL] [Abstract][Full Text] [Related]
9. [Chitosan-coated ophthalmic submicro emulsion for pilocarpine nitrate].
Wei J; He HL; Zheng CL; Zhu JB
Yao Xue Xue Bao; 2011 Aug; 46(8):990-6. PubMed ID: 22007526
[TBL] [Abstract][Full Text] [Related]
10. Rheological analysis and mucoadhesion: A 30 year-old and still active combination.
Rossi S; Vigani B; Bonferoni MC; Sandri G; Caramella C; Ferrari F
J Pharm Biomed Anal; 2018 Jul; 156():232-238. PubMed ID: 29729636
[TBL] [Abstract][Full Text] [Related]
11. Synergistic interaction between TS-polysaccharide and hyaluronic acid: implications in the formulation of eye drops.
Uccello-Barretta G; Nazzi S; Zambito Y; Di Colo G; Balzano F; Sansò M
Int J Pharm; 2010 Aug; 395(1-2):122-31. PubMed ID: 20580791
[TBL] [Abstract][Full Text] [Related]
12. Poly(amidoamine) dendrimers as ophthalmic vehicles for ocular delivery of pilocarpine nitrate and tropicamide.
Vandamme TF; Brobeck L
J Control Release; 2005 Jan; 102(1):23-38. PubMed ID: 15653131
[TBL] [Abstract][Full Text] [Related]
13. Inlfuence of high-viscosity vehicles on miotic effect of pilocarpine.
Schoenwald RD; Ward RL; DeSantis LM; Roehrs RE
J Pharm Sci; 1978 Sep; 67(9):1280-3. PubMed ID: 690834
[TBL] [Abstract][Full Text] [Related]
14. Rheological and mucoadhesive characterization of polymeric systems composed of poly(methylvinylether-co-maleic anhydride) and poly(vinylpyrrolidone), designed as platforms for topical drug delivery.
Jones DS; Lawlor MS; Woolfson AD
J Pharm Sci; 2003 May; 92(5):995-1007. PubMed ID: 12712419
[TBL] [Abstract][Full Text] [Related]
15. A novel poloxamers/hyaluronic acid in situ forming hydrogel for drug delivery: rheological, mucoadhesive and in vitro release properties.
Mayol L; Quaglia F; Borzacchiello A; Ambrosio L; La Rotonda MI
Eur J Pharm Biopharm; 2008 Sep; 70(1):199-206. PubMed ID: 18644705
[TBL] [Abstract][Full Text] [Related]
16. Physico-chemical, in vitro and in vivo characterisation of polymers for ocular use.
Hartmann V; Keipert S
Pharmazie; 2000 Jun; 55(6):440-3. PubMed ID: 10907252
[TBL] [Abstract][Full Text] [Related]
17. Selected polysaccharides at comparison for their mucoadhesiveness and effect on precorneal residence of different drugs in the rabbit model.
Di Colo G; Zambito Y; Zaino C; Sansò M
Drug Dev Ind Pharm; 2009 Aug; 35(8):941-9. PubMed ID: 19280528
[TBL] [Abstract][Full Text] [Related]
18. Vehicle effects on ophthalmic bioavailability: the influence of different polymers on the activity of pilocarpine in rabbit and man.
Saettone MF; Giannaccini B; Teneggi A; Savigni P; Tellini N
J Pharm Pharmacol; 1982 Jul; 34(7):464-6. PubMed ID: 6126549
[No Abstract] [Full Text] [Related]
19. Niosomes as carriers for ophthalmic drugs: in vitro/in vivo evaluation.
Perini G; Saettone MF; Carafa M; Santucci E; Alhaique F
Boll Chim Farm; 1996 Feb; 135(2):145-6. PubMed ID: 8791827
[No Abstract] [Full Text] [Related]
20. In situ gelling xyloglucan formulations for sustained release ocular delivery of pilocarpine hydrochloride.
Miyazaki S; Suzuki S; Kawasaki N; Endo K; Takahashi A; Attwood D
Int J Pharm; 2001 Oct; 229(1-2):29-36. PubMed ID: 11604255
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
